New approach improves exosome isolation in urine, suggesting liquid biopsy could advance molecular diagnostics.
Urine-based liquid biopsy and exosomes constitute exceptional noninvasive techniques for detecting valuable biomarkers associated with diverse diseases. However, current exosome isolation methods struggle to recover sufficient intact exosomes from a large volume of diluted urine, limiting high detection sensitivity. Here, we present a highly sensitive method for detecting exosome markers using microfluidics-based biologically intact exosome separation technology (BEST), which isolates and enriches exosomes from human urine. Numerical simulations demonstrate that hydrodynamic wall repulsion and suction-driven drag forces segregate 100 nm particles representing exosomes from 8 μm particles, indicating apoptotic bodies or larger particles with complete purity, consistent with experiments. We also show a separation purity of 72.4% for urinary exosomes at a suction flow rate of 95 μL/min. Using concentrated exosomes, PCR and Western blotting sensitivities increase by 4.7 and 4.0-fold, respectively, compared with unprocessed pooled urine. Our methodology possesses considerable potential for future molecular diagnostics, necessitating heightened sensitivity.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: